These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3456495)

  • 1. Aztreonam: preclinical studies.
    Bonner DP; Tanaka SK; Schwind RA
    N J Med; 1986 Jan; Spec No():20-5. PubMed ID: 3456495
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of 89,517 gram-negative isolates to aztreonam and other antibiotics.
    Lindsay G; Woods P
    Chemioterapia; 1987 Jun; 6(2 Suppl):106. PubMed ID: 3509363
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
    Monaci E; Monaci R; Giacalone G; Meoni S
    Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro activities of aztreonam and sulbactam/ampicillin for gram-negative bacteria].
    Ozkuyumcu C; Durupinar B; Dikmen N
    Mikrobiyol Bul; 1989 Jan; 23(1):77-9. PubMed ID: 2626099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies with aztreonam, a new monobactam antibiotic.
    Peddie BA
    N Z Med J; 1986 Apr; 99(799):249. PubMed ID: 3458073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azthreonam: in vitro activity.
    Gobernado M; Cantón E; Santos M
    Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibacterial mechanisms of synthetic monobactams against gram-negative bacilli].
    Mitsui K
    Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):373-90. PubMed ID: 3504872
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of chemotherapeutic antagonism in opportunistic infections.
    Castelli M; Baggio G; Ruberto AI; Malagoli M; Casolari C; Rossi T; Galatulas I
    Anticancer Res; 1997; 17(6D):4339-44. PubMed ID: 9494530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects and challenges of developing new agents for tough Gram-negatives.
    Meyer AL
    Curr Opin Pharmacol; 2005 Oct; 5(5):490-4. PubMed ID: 16084769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aztreonam: a new concept in beta-lactam antibiotics.
    Fernandes PB; Bonner DP; Sykes RB
    Compr Ther; 1983 May; 9(5):21-6. PubMed ID: 6682744
    [No Abstract]   [Full Text] [Related]  

  • 19. Aztreonam.
    Outman WR
    Conn Med; 1987 Sep; 51(9):611-3. PubMed ID: 3311617
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.